Case study: Reduce plate counts with rapid microbial monitoring

Find out how a pharma company maintained product quality and reduced plate counts by 25 percent using a rapid microbial monitoring analyser – the 7000RMS.

To remain competitive in the global marketplace, biotech and pharmaceutical companies focus on optimising costs while improving efficiency and mitigating risk. This case study explains how a pharmaceutical company in China addresses this challenge through real-time microbial detection used in parallel with plate counts to reduce bioburden monitoring costs while also implementing a more comprehensive process control strategy.

READ FOR FREE HERE